BioSpace News Archive

Ortho Regenerative Technologies Inc . (CSE: ORTH) (OTCQB: ORTIF) a clinical stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced today the appointment of Patrick O’Donnell to its Board of Directors

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast a presentation from the 41st Annual Cowen Healthcare Conference.

LivaNova PLC, a market-leading medical technology and innovation company, reported results for the quarter and full-year ended December 31, 2020.

Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has announced it has submitted a Biologics License Application to the U.S. Food and Drug Administration for its investigational freeze dried plasma candidate.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that three posters featuring data on smoker and e-cigarette user behavior will be presented , Wednesday, February 24th at the SRNT Annual Meeting being held virtually.

AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today the appointment of James Sapirstein, President and CEO, as chairman of the company’s board of directors, effective immediately. Mr. Sapirstein succeeds Mr. Edward J. Borkowski,

Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation therapies targeting the tumor microenvironment, today announced that Rob Ross, M.D., incoming chief executive officer, will participate in the following virtual investor conferences: Cowen 41 st Annual Healthcare Conference, Monday, March 1, 2021, at 10:20 a.m. ET as part of the Novel IO panel. H.C. Wainwright Global Life Sciences

Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage company developing treatments to restore and improve hearing and balance, presented preclinical data supporting the company’s gene therapy product candidate, DB-OTO, a potential transformative treatment for individuals with hearing loss due to mutation of the otoferlin gene. T

Global health service company Cigna Corporation announced that Brian Evanko, executive vice president and chief financial officer, will present at the Barclays Global Healthcare Conference, Mar. 10, 2021, through a virtual webcast.

Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that enhance feed intake and safely support immune function, thereby supporting general health and performance, is pleased to announce that it has chosen Meyenberg International Group to lead expansion efforts in key regions in Central and South America.